摘要
抗生素的耐药性升级减少了目前可用的抗菌药物的效用。这种威胁的一部分归因于药物的不良药代动力学和药效学。药物生产的改进是制药工业所面临的最具挑战性的任务,然而纳米技术可以给药物输送设计带来一场革命。纳米抗菌剂(NAMS)有其固有的抗菌活性(纳米颗粒)或增加附抗生素的总体疗效(纳米载体),从而有助于减轻或逆转耐药现象。纳米颗粒(NPs)具有自身固有的抗菌活性通过模仿由吞噬细胞即自然杀伤微生物杀灭,通过产生大量活性氧(ROS)和活性氮(RNS)。纳米颗粒通过同时作用于许多重要的生命过程或微生物的代谢途径来杀死微生物,以至于许多对它们产生抗性的基因突变似乎是不可能的。纳米载体改善封闭药物的药代动力学。此外,一个主要的技术,即纳米抗菌剂能克服阻力是有针对性的药物输送到病患部位。这篇综述是对纳米抗菌剂作用机制的综合背景中的多药耐药现象的综合总结。
关键词: 纳米抗菌药物,多药耐药,纳米颗粒,纳米载体系统,行动方式,活性氧(ROS)和活性氮(RNS)。
图形摘要
Current Drug Targets
Title:Mechanism of Action: How Nano-Antimicrobials Act?
Volume: 18 Issue: 3
Author(s): Bushra Jamil, Habib Bokhari, Mohammad Imran.
Affiliation:
关键词: 纳米抗菌药物,多药耐药,纳米颗粒,纳米载体系统,行动方式,活性氧(ROS)和活性氮(RNS)。
摘要: Escalating resistance to almost every class of antibiotics is reducing the utility of currently available antimicrobial drugs. A part of this menace is attributed to poor pharmacokinetics and pharmacodynamics of the drug. Improvement in drug delivery is the most challenging task encountered by the pharmaceutical industries; however nanotechnology can bring a revolution in drug delivery design. Nano-antimicrobials (NAMs) have their own intrinsic antimicrobial activity (nanoparticles) or augment overall efficacy of enclosed antibiotics (nano-carriers), thus contribute in mitigating or reversing the resistance phenomenon. Nano-particles (NPs) having their own intrinsic antimicrobial activity kill microbes by mimicking natural course of killing by phagocytic cells i.e., by producing large quantity of Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS). It is believed that NPs kill microbes by simultaneously acting on many essential life processes or metabolic routes of microbes; that as many genetic mutations to develop resistance against them seems to be impossible. Nano carriers improve the pharmacokinetics of the enclosed drug. Moreover, one of the major techniques by which NAMs can overcome resistance is targeted drug delivery to the site of disease. In this review, a comprehensive detail about the mechanism of action of NAMs are presented in context to multi drug resistance phenomenon.
Export Options
About this article
Cite this article as:
Bushra Jamil, Habib Bokhari, Mohammad Imran. , Mechanism of Action: How Nano-Antimicrobials Act?, Current Drug Targets 2017; 18 (3) . https://dx.doi.org/10.2174/1389450116666151019101826
DOI https://dx.doi.org/10.2174/1389450116666151019101826 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis of Gold Mediated Biocompatible Nanocomposite of Lactone Enriched Fraction from Sahadevi (Vernonia cinerea Lees): An Assessment of Antimalarial Potential
Current Topics in Medicinal Chemistry In Silico Screening for Potent Inhibitors against the NS3/4A Protease of Hepatitis C Virus
Current Pharmaceutical Design Expression, Purification, Crystallization and Preliminary X-Ray Crystallographic Analysis of the Resuscitation Promoting Factor Interacting Protein RipA from M. tuberculosis
Protein & Peptide Letters Synthesis of Novel and Highly Functionalized 4-hydroxycoumarin Chalcone and their Pyrazoline Derivatives as Anti-Tuberculosis Agents
Letters in Drug Design & Discovery The Unbiased Search of Biomarkers in Neurodegenerative Diseases
Current Pharmaceutical Biotechnology An Overview on Pyranocoumarins: Synthesis and Biological Activities
Current Organic Chemistry HIV Genomic Mutations Causing Resistance to Antiretroviral Drugs in Seropositive Sicilians
Current HIV Research Drug Evolution Concept in Drug Design: 2. Chimera Method
Medicinal Chemistry Synthesis, Characterization and In Vitro Antiproliferative Effects of Novel 5-Amino Pyrazole Derivatives against Breast Cancer Cell Lines
Recent Patents on Anti-Cancer Drug Discovery Inhibition of Major Drug Metabolizing CYPs by Common Herbal Medicines used by HIV/AIDS Patients in Africa– Implications for Herb- Drug Interactions
Drug Metabolism Letters Anti-Tuberculosis
Current Bioactive Compounds Human Anthrax as a Re-Emerging Disease
Recent Patents on Anti-Infective Drug Discovery Self-Adjuvanting Lipopeptide Vaccines
Current Medicinal Chemistry Editorial (Hot Topic: Proteolytic Inhibitors: Implications on Microorganisms Development, Virulence and Pathogenesis)
Current Medicinal Chemistry Neglected Aspects of Drug Discovery - Microbiological Aspects
Current Clinical Pharmacology Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews Editorial [Hot Topic: Bacterial Vectors for Gene & Cell Therapy (Guest Editors: Mark Tangney & Cormac G.M. Gahan)]
Current Gene Therapy Direct Evidence for GC-NSF(a) Hypothesis on Creation of Entirely New Gene/Protein
Current Proteomics The Contribution of Host Genetics to TB Disease
Current Respiratory Medicine Reviews Biological Activities and In Silico Physico-Chemical Properties of 1,2,3- Triazoles Derived from Natural Bioactive Alcohols
Anti-Infective Agents